Members of our chapter can help accelerate the pace of type 1 diabetes (T1D) research by raising funds for the JDRF Golf & Tennis Classic Fund A Cure campaign. All you have to do is create your own fundraising page with your personal story and share the link by sending emails to your contacts and asking them to donate to Fund-A-Cure, especially if they are not likely to attend the Golf & Tennis Classic. For more information on starting your own campaign, contact Sandy Hilsenrath at email@example.com or call 732-219-6654.
Click here to join!
JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF collaborates with a wide spectrum of partners and is the only organization with the scientific resources, regulatory influence, and a working plan to better treat, prevent, and eventually cure T1D. As the largest charitable supporter of T1D research, JDRF is currently sponsoring $568 million in scientific research in 17 countries. For more information, please visit www.jdrf.org.
Fund A Cure is a unique opportunity to make a 100 percent tax-deductible donation to JDRF that will fund critical type 1 diabetes (T1D) research. Since 1994, JDRF has raised more than $211 million through the Fund A Cure campaign alone.
We're the stop at nothing type
exists for the millions of children, adults, and families affected by
type 1 diabetes (T1D) every single day. Their determination to overcome
this disease strengthens ours to end it by funding life-changing T1D
an autoimmune disease in which a person's pancreas loses the ability to
produce insulin — a hormone essential to turning food into energy. It
strikes both children and adults suddenly and is unrelated to diet and
lifestyle. It requires constant carbohydrate counting, blood-glucose
testing, and lifelong dependence on injected insulin.
participation in JDRF events ensures that JDRF can continue funding
critical T1D research. With your support, this research will continue to
bring us closer to a world without T1D.